Nrf2 negatively regulates melanogenesis by modulating PI3K/Akt signaling

Jung-Min Shin1, Mi Yoon Kim1, Kyung-Cheol Sohn1

  • 1Department of Dermatology and Research Institute for Medical Sciences, School of Medicine, Chungnam National University, Daejeon, Korea.

Plos One
|April 26, 2014
PubMed

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) inhibits melanogenesis, the process of melanin production. Nrf2 activation decreases melanin synthesis and key enzyme expression in human melanocytes via the PI3K/Akt pathway.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Dermatology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor crucial for cellular defense against oxidative stress and xenobiotics.
  • Nrf2 regulates the expression of numerous cytoprotective genes.
  • The role of Nrf2 in melanogenesis, the process of melanin pigment production, is not well understood.

Purpose of the Study:

  • To investigate the effect of Nrf2 on melanogenesis in normal human melanocytes (NHMCs).
  • To elucidate the molecular mechanisms underlying Nrf2's influence on melanin synthesis.

Main Methods:

  • Normal human melanocytes (NHMCs) were transduced with a recombinant adenovirus expressing Nrf2.
  • Expression levels of melanogenesis-related genes (tyrosinase, tyrosinase-related protein 1) were analyzed.
  • The role of Keap1, an Nrf2 regulator, was assessed.
  • PI3K/Akt signaling pathway activation was investigated using wortmannin, a PI3K inhibitor.

Main Results:

  • Overexpression of Nrf2 in NHMCs led to a significant decrease in melanin synthesis.
  • Nrf2 overexpression reduced the expression of tyrosinase and tyrosinase-related protein 1.
  • The inhibitory effect of Nrf2 on melanogenesis was reversed by Keap1 overexpression.
  • Nrf2 overexpression activated the PI3K/Akt signaling pathway.
  • Inhibition of PI3K activity with wortmannin reversed the depigmentary effects of Nrf2.

Conclusions:

  • Nrf2 negatively regulates melanogenesis in normal human melanocytes.
  • Nrf2 exerts its depigmentary effects by modulating the PI3K/Akt signaling pathway.
  • These findings identify Nrf2 as a potential target for modulating skin pigmentation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.6K